Microsoft's record-setting deal to buy soil carbon credits highlights a major corporate push to offset emissions using nature-based solutions like regenerative agriculture. This trend opens up a compelling investment opportunity in companies that enable, verify, and scale the market for high-quality carbon removal.
Published on January 15
Microsoft's record-breaking carbon credit purchase signals that tech giants are seriously investing in nature-based climate solutions. This creates massive market opportunities for companies in the regenerative agriculture space.
As the voluntary carbon market matures, companies that can verify, scale, and deliver high-quality carbon removal are positioned to capture significant market share in this emerging industry.
From precision farming technology to biological crop solutions, these companies are at the forefront of transforming agriculture into a profitable climate solution that benefits both farmers and corporations.
Microsoft's record-breaking purchase of soil carbon credits signals a major shift towards nature-based climate solutions. This creates investment opportunities in companies that enable, verify, and scale carbon removal through regenerative farming practices.
This collection spans the agricultural value chain, from precision farming technology to biological crop solutions and carbon credit platforms. These companies are positioned to benefit from growing corporate demand for high-quality carbon offsets.
Each stock was handpicked by professional analysts based on their role in enabling regenerative agriculture and carbon sequestration. They represent key players from tech giants to agricultural innovators driving this emerging market.
This basket's total market capitalisation is $3.61T and is heavily anchored by a single dominant large-cap position, producing a concentrated large-cap profile. That concentration generally implies lower volatility and market-like behaviour, rather than high-growth dispersion.
MSFT: $3.41T
DE: $138.50B
CTVA: $47.26B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+68.07%
On average, analysts expect assets in this group to grow 68.07% over the next year.
10 of 14 assets in this group are rated Buy by professional analysts.
